Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Parietaria Judaica

Inclusion Criteria: * Informed consent, signed by the subject * Positive clinical history of rhinitis/rhinoconjunctivitis allergy to Parietaria pollen * Patient of both gender aged from 18 up to 55 * Diagnosed Sensitivity to Parietaria pollen base on: Positive Nasal provocation test Positive prick test to P. Judaica Specific IgE to P.Judaica \>0,7KU/L \- Patients who are able to comply with the dose regime Exclusion Criteria: * Relevant sensitivity to another perenne allergen * Patient with asthma * Use of immunotherapy during the last four years * Treatment with B. Blocking agents * Patient suffering from some pathology in which adrenaline was contraindicated * Subject suffers from a serious medical condition, which would interference the treatment and follow up of the subject in the study * Subject suffers from autoimmune disease(thyroiditis, lupus, etc.) * Conditions in which the patient can not offer full co-operation nad significant psychiatric disturbance. * Intolerance to aspirin * Pregnant women or with pregnancy risk and brest-feeding